HealthEquity, Inc. (NASDAQ:HQY) Stock Position Lowered by Advantage Alpha Capital Partners LP

Advantage Alpha Capital Partners LP lowered its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 13.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 72,013 shares of the company's stock after selling 11,079 shares during the quarter. HealthEquity accounts for about 1.6% of Advantage Alpha Capital Partners LP's portfolio, making the stock its 13th biggest holding. Advantage Alpha Capital Partners LP owned 0.08% of HealthEquity worth $6,910,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the stock. Wealthfront Advisers LLC acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $10,304,089,000. Vanguard Group Inc. raised its stake in shares of HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock valued at $861,256,000 after acquiring an additional 99,624 shares in the last quarter. Wasatch Advisors LP increased its holdings in HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company's stock worth $635,065,000 after purchasing an additional 483,269 shares during the period. State Street Corp raised its holdings in HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company's stock valued at $256,346,000 after acquiring an additional 23,613 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of HealthEquity by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company's stock worth $170,197,000 after purchasing an additional 15,145 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Remove Ads

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares of the company's stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HQY. Wells Fargo & Company raised their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Barrington Research reiterated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday, March 14th. Mizuho began coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price target for the company. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price target for the stock from $120.00 to $115.00 in a research note on Tuesday. Finally, The Goldman Sachs Group cut their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $112.23.

HealthEquity Stock Up 1.2 %

HQY traded up $1.05 during trading on Thursday, hitting $90.27. The company had a trading volume of 644,289 shares, compared to its average volume of 705,605. The business has a 50-day moving average of $104.17 and a 200-day moving average of $95.89. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a market cap of $7.81 billion, a PE ratio of 82.80, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.